Rheumatic Joint Disease clinical trials at UCSF

1 research study open to eligible people

Rheumatic joint disease is a condition that damages and inflames joints. UCSF captures detailed information about children with these diseases to learn more about them. Studying such patients helps in understanding how these diseases develop in the early stages.

Showing trials for

  • Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

    open to eligible people ages up to 21 years

    Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

    San Francisco, California and other locations

Our lead scientists for Rheumatic Joint Disease research studies include .

Last updated: